Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review.

about

Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study

P2860

Q58600801-F5175200-A70C-42C3-9FF5-1339A888C9C8

P2860

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review.

Item

http://www.wikidata.org/entity/Q41544213

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Extracellular cardiac matrix b ...... therapy: a systematic review.

@en

type

Item

label

Extracellular cardiac matrix b ...... therapy: a systematic review.

@en

prefLabel

Extracellular cardiac matrix b ...... therapy: a systematic review.

@en

P1476

Extracellular cardiac matrix b ...... n therapy: a systematic review

@en

P2093

Christopher J McAloon

http://www.w3.org/2001/XMLSchema#string

Danish Ali

http://www.w3.org/2001/XMLSchema#string

Faizel Osman

http://www.w3.org/2001/XMLSchema#string

Harpal Randeva

http://www.w3.org/2001/XMLSchema#string

Paul O'Hare

http://www.w3.org/2001/XMLSchema#string

Thomas Hamborg

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.

Membrane-associated matrix proteolysis and heart failure.

Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.

Emerging biomarkers in heart failure.

P304

e000639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/OPENHRT-2017-000639

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Prithwish Banerjee

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28878953

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

biomarker

P932

5574440

http://www.w3.org/2001/XMLSchema#string

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review.

about

P2860

P2860

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932